Heart Disease Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who have a medical reason to undergo a coronary CT angiography (a special heart scan that looks at the arteries of the heart)
- People who have read and signed a written consent form agreeing to take part
Who may not be able to join:
- People whose heart pumps at less than 35% of its normal capacity
- People who have had a severe type of heart attack (called an ST-elevation myocardial infarction) within the past 72 hours, or who have previously had bypass surgery on the heart's arteries
- People whose blood flow through the heart arteries is not normal, based on a specific medical measurement (confirm with trial site)
- People who are scheduled to have heart bypass surgery after their diagnostic heart scan
- People whose heart CT scan images are too poor in quality, or whose scan results are considered unsuitable for analysis of plaque, blood flow, or surrounding fat tissue, as determined by the trial's reviewing laboratory
- People who have a stent (a small tube used to keep an artery open) in the heart artery being studied
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Junbo Ge, Professor, Fudan University
Phone: +8613701997266
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Frequency of occurrence of high-risk plaques; Change in total plaque volume (adjusted by vessel volume) and plaque composition detected by follow up CCTA; Change in WSS detected by follow up CCTA; Change in APS detected by follow up CCTA; Change in SSI detected by follow up CCTA; Change in hemodynamic parameters delta fractional flow reserve detected by follow up CCTA; Change in physiological pattern by PPG derived by follow up CCTA; Change in dCT-FFR/ds detected by follow up CCTA; Change in CT-FFR; Change in peri-coronary adipose tissue assessed by follow up CCTA; CCTA-derived features associ...
Can't join this trial?
Data last synced from ClinicalTrials.gov: 21 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.